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TITLE: ROLE OF FNAC IN ORBITAL AND EYELID LESIONS 
AIM : To study the role of FNAC in eyelid and orbital lesions in comparision to 
biopsy. 
Materials and methods : 40 patients with eyelid (24) and orbital lesions  (16) 
were subjected to FNAC and then later to Biopsy and the results were compared 
and tabulated. Only firm eyelid lesions >5mm in size and anterior orbital lesions 
were included in the study. 
RESULTS :  This shows that FNAC in eyelid and orbital lesions is a reliable 
diagnostic tool with histopathological correlation of >80 % in orbital lesions 
and correlation of 91.3%The sensitivity of FNAC for malignant lesions to be 
88% and its specificity to be 100%.The positive predictive value of FNAC for 
malignant lesions is 100% and negative predictive value is 89%. 
CONCLUSION :  FNAC gives rapid results and correlates highly with Tissue 
biopsy proven HPE, FNAC can be considered as a primary investigation in the 
diagnosis of eyelid and anterior orbital lesions and can be done safely as an 
outpatient procedure. 
Keywords : FNAC , Biopsy , HPE , Anterior orbital lesion , eyelid lesion  
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CLINICAL ANATOMY OF THE ORBIT 
The orbit is a pear shaped cavity enclosing a volume of about 30ml and 
made up of 7 bones. 
The orbit contains the eyeball and extraocular muscles, nerves, vascular 
elements, lacrimal gland and the spaces between them are completely 
filled with lobules of orbital fat and connective tissue fascia. 
The orbitalseptum separates the anterior orbit from the eyelid. The orbital 
apex is the posterior end where the four walls of the orbit converge.  
The seven bones forming the orbital walls are fig (1): 
1. Frontal  
2. Ethmoid ,  
3. Maxillary ,  
4. Palatine ,  
5. Sphenoid  
6. Lacrimal and 
7. Zygomatic bones. 
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The orbital bones contributing to the walls of the orbit are as follows: 
Roof 
    Frontal bone 
   
 Lesser wing of the sphenoid 
bone 
 
Medial Wall 
   
 Frontal process of the 
maxillary bone 
    Lacrimal bone 
    Ethmoid bone 
    Body of the sphenoid bone 
 
 
Floor 
    Maxillary bone 
    Zygomatic bone 
    Palatine bone 
   
 
 
Lateral Wall 
    Zygomatic bone 
   
 Greater wing of the sphenoid 
bone 
 
 
THE BASE OF THE ORBIT: 
The anterior open end of the orbit is called as the base. A ring of compact 
bone forms the orbital margins. They are the following: 
Superior margin 
Formed by orbital arch of 
frontal bone 
Lateral orbital margin 
Formed by zygomatic bone and 
zygomatic process of frontal 
bone 
Strongest part of the base. 
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Inferior margin 
Formed by zygomatic bone and 
zygomatic process of frontal 
bone 
Medial orbital margin 
Upper part formed by frontal 
bone and continuous with 
posterior lacrimal crest  
Lower part formed by anterior 
lacrimal crest on frontal process 
of maxilla 
 
 
THE APEX OF THE ORBIT 
The apex of the orbit refers to the posterior end of the orbit, fig (1), where 
the four orbital walls converge and it contains  
1.  Optic canal – which transmits the optic nerve and Ophthalmic 
artery 
2. Superior orbital fissure – which is further divided into upper , 
middle and lower parts by the common tendinous ring 
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Upper part transmits – lacrimal nerve, frontal nerve, 
trochlear nerve, recurrent branch of ophthalmic artery and 
superior ophthalmic vein 
Middle part transmits - superior and inferior division of 
oculomotor nerve, nacociliary nerve and abducent nerve. 
Lower part – transmits inferior ophthalmic vein. 
Fig 1. Showing the 7 bones forming the orbital walls, the Base & the apex 
of the orbit  
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PERIORBITA: 
The surface of the orbital bones is lined by periosteum. This is known as 
periorbita. It is usually loosely attached to the bone .At the sutural sites, 
lacrimal fossa, superior and inferior fissures and the orbital margins, the 
periorbita is firmly attached. Also the ring of Zinn is formed by the 
thickening of the periorbita. 
ORBITAL FASCIA:It is the lining of the intraorbital structures and 
is a thin membrane made up of connective tissue.  
The orbital fascia can be studied under the following headings: 
 The Fascial sheaths of the extraocular muscles 
 Intermuscular septa 
 Fascial expansions – capsulopalpebral fascia , Suspensory 
ligament of Lockwood , superior transverse ligament of Whitnall 
 Tenon’s capsule or Fascia bulbi – which lines the globe from 
limbus to the optic disc but is separated from the sclera by a 
potential subtenons space. 
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The othercontents of the Orbitare as follows: 
The eyeball:About one fifth of the orbital volume is occupied by the 
eyeball. 
Muscles:  The extraocular muscles originate from the walls of the 
orbit to insert onto the globe which include the four recti muscles – 
Superior,Medial,Lateral, inferior recti and the obliques – superior and 
inferior obliques. 
Nerves: The nerves contained in the orbit are  
 the Optic Nerve ,  
 the oculomotor nerve , trochlear nerve ,  abducent 
nerve -innervate the extraocular muscles   
 Branches of Ophthalmic and Maxillary division of 
Trigeminal nerve. 
Blood vessels: Ophthalmic artery and its branches, branch of middle 
meningeal artery, infra orbital vessels and the superior and inferior 
ophthalmic veins. 
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ORBITAL FAT:Occupies most of the orbital cavity and is divided by 
intermuscular septa into central and peripheral parts anteriorly while 
posteriorly the central and peripheral parts are continuous. 
Lacrimal gland. 
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SURGICAL SPACES OF THE ORBIT: 
The various connective tissue structures divides the orbit into various 
spaces of surgical importance and are as follows:fig (2) 
 Sub Tenon’s space - The potential space between the sclera and 
subtenons.  
 Anterior (peripheral) space – bound anteriorly by septum orbitale, 
posteriorly merges with the central space, internally by 
extraocular muscles and their septa and peripherally by the 
periorbita. 
 Posterior / Central space: bounded anteriorly by the fascia bulbi, 
posteriorly continuous with the peripheral orbital space, and 
peripherally by the extraocular muscles and their septa. Also 
called retrobulbar space.  
 Apical space: anteriorly merges with anterior and central spaces, 
peripherally by periorbita, and posteriorly ends at the apex of the 
orbit. 
 Sub-periosteal space: A potential space between the periorbita and 
the orbital bones. Strong adhesions between the orbital bones and 
the periorbita limit the space anteriorly.  
18 
Fig (2) surgical spaces of the orbit 
 
 
Fig showing section of orbit at various levels dividing into surgical spaces. 
Sagittal section above and corresponding coronal sections at levels A,B,C 
showing 1.subperiosteal space 2.peripheral space 3.central space 4.Tenons 
space 5.orbital apex showing merging of peripheral and central spaces.  
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LESIONS OF ORBIT BASED ON PATHOPHYSIOLOGY 
INFECTIONS 
 
Preseptal cellulitis 
Bacterial orbital cellulitis 
Rhino-orbital mucormycosis 
 
NON-INFECTIVE 
INFLAMMATORY 
DISEASE 
Idiopathic orbital inflammatory disease 
Orbital myositis 
Acute dacryoadenitis 
Tolosa–Hunt syndrome 
Wegener granulomatosis 
 
VASCULAR 
MALFORMATIONS 
Varices 
Lymphangioma 
 
CYSTIC LESIONS 
 
Dacryops 
Dermoid cyst 
Sinus mucocele 
Encephalocele 
 
TUMOURS 
Capillary haemangioma 
Cavernous haemangioma 
Pleomorphic lacrimal gland adenoma 
Lacrimal gland carcinoma 
Optic nerve glioma 
Optic nerve sheath meningioma 
Plexiform neurofibroma 
Isolated neurofibroma 
Lymphoma 
Embryonal sarcoma 
Adult and childhood metastatictumours 
Orbital invasion from adjacent structures 
 Direct and indirect carotid cavernous fistula 
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ORBITAL LESIONS DEPENDING ON LOCATION  
SUBPERIOSTEAL SPACE Dermoid and Epidermoid cyst , 
subperiosteal abscess ,hematoma 
fibrous dysplasia , expanding 
mucocele 
PERIPHERAL / ANTERIOR 
ORBITAL SPACE 
Lymphoma  
Capillary Hemangioma 
Lacrimal gland tumour 
Pseudotumour 
CENTRAL SPACE Cavernous hemangioma  
Meningioma  
Optic Nerve Glioma 
Solitary Neurofibroma  
APICAL SPACE Pseudotumour 
Meningioma 
SUB TENONS SPACE Abscess 
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CLINICAL ANATOMY OF THE EYELIDS 
They are mobile tissue curtains placed in front of the eyes and serve in 
protecting the globe.  
The various functions of the eyelids are the following: 
1. Help spread the tear film evenly over the surface of the eye.  
2. The eyelids collect tears and propel them to the medial canthus, 
where they enter the lacrimal drainage system.  
3. The eyelashes protect the cornea from glare and injury by 
sweeping particles from the front of the eye and reflex movements. 
The eyelids consists of the following layers:Fig (3) 
 Skin 
 Subcutaneous areolar tissue 
 Striated muscle – Orbicularis oculi and Levator palpebra 
superioris 
 Submuscular areolar tissue – contains nerves and vessels  
 Fibrous layer – Tarsal plate and orbital septum 
 Non – striated muscle fibres – Mullers muscle 
 Conjunctiva 
22 
 
Layers of the eyelid 
 
 
 
 
 
 
 
 
 
Fig (3) showing cross section of the eyelid 
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ORBICULARIS OCULI: 
The Orbicularis oculi is supplied by the Facial nerve (CN7) and can be 
divided into the Orbital portion & Palpebral portion. 
1. Orbital portion - overlies the bony orbital rims 
2. Palpebral portion – a) Preseptal part - over the orbital septum in 
both upper and lower eyelids. 
 b) The pretarsal portion of the muscle overlies the tarsal 
plates.Medially, the pretarsal fibers fuse to form a prominent bundle of 
fibers called Horner’s muscle, whichhelps in the lacrimal pump drainage 
by maintaining the posterior position of the canthal angle & tightens the 
eyelids against the globe during eyelid closure. 
Orbital Septum 
The orbital septum is a thin, fibrous membrane that begins at the orbital 
rim. Distal fibres of the orbital septum merge into the anterior surface of 
the levator aponeurosis. The point of insertion usually is about 3–5mm 
above the tarsal plate.  In the lower eyelid the septum fuses with the 
capsulopalpebral fascia and gives rise to the common fascial sheet which 
inserts onto the lower border of the tarsus 
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EYELID RETRACTORS 
They consist of the levator palpebrae and Müller’s muscles in the upper 
lid. 
The LPS arises from the lesser wing of sphenoid and runs forward above 
the superior rectus muscle. A condensation is seen along the muscle 
sheath, at the superior orbital rim,called the transverse orbital ligament of 
Whitnall from where the muscle continues downward as its aponeurosis 
for about 14–20mm before it insertsonto the tarsal plate. At the upper 
edge of the tarsus, this aponeurosis sends numerous interconnecting slips 
forward and downward whichgets inserts ontothe pretarsal orbicularis 
muscle and subcutaneous tissue, which ultimately forms the lid crease.  
Müllers muscle originates from the undersurface of the LPS and inserts 
onto the anterior edge of the superior tarsal border and receives 
sympathetic innervation. Lesion in this sympathetic pathway causes 
HORNER’S syndrome. 
In the lower eyelid, the sheaths around the inferior rectus, inferior oblique 
and the Lockwood’s ligament gives rise to the capsulopalpebral 
fascia.This fibrous sheet passes upward,fuses with fibers of the orbital 
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septum and gives rise to the common fascial sheet which inserts onto the 
lower border of the tarsus.  
TARSAL PLATES: 
They impart structural integrity to the each eyelid. The width of each 
plate is about 25mm and the height of the tarsal plates in the upper eyelid 
is 8–12mm and 3.5–4mm in the lower eyelid and . About 25 Meibomian 
glands are located within the upper tarsus and 20 in the lower tarsus. 
They produce the lipid layer of the precorneal tear film. 
CONJUNCTIVA: 
It is a mucous membrane which lines the anterior surface of the globe and 
the posterior surface of the eyelids and contains small accessory lacrimal 
glands within the sub mucosal connective tissue. It can be divided into: 
1. The palpebral conjunctiva which lies closely along the posterior 
surface of tarsal plate and Mullers muscle. 
2. The bulbar conjunctiva. It is continuous with the palpebral 
portion above and below atthe furnaces.  
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LESIONS OF EYELID: 
Can be divided into benign and malignant lesions. 
Benign nodules & cysts : 
Chalazion 
Dermoid 
Epidermoid cyst 
Epidermal inclusion cyst 
Cyst of moll & Zeis 
Benign epidermal tumors : 
Squamous cell papilloma 
Basal cell papilloma 
Actinic keratosis 
 
Benign adnexal tumours 
Syringoma 
Pilomatricoma 
Benign pigmented lesions  
 
Freckle 
Congenital / acquired melanocytic 
nevus 
Miscellaneous benign tumours 
Capillary hemangioma 
Neurofibroma 
 
Malignant tumours 
Basal cell carcinoma 
Keratoacanthoma 
Squamous cell carcinoma 
Sebaceous cell carcinoma 
Melanoma 
Merkel cell carcinoma 
Kaposi sarcoma 
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DIAGNOSIS OF LESIONS 
 
The diagnosis of the various orbital and eyelid lesions are done in a 
stepwise approach: 
1. History taking and physical examination: to determine if the 
disease is characterized by features of inflammation, infiltration, 
vascular change or mass effect, and it helps define the location of 
the lesion. 
 
2. Imaging techniques– helps localize the lesion ,define relationship 
of lesion and its effect on adjacent structures. Also defines its 
surface features and infiltrative effects if any. Imaging can also 
give an idea as to the compressibility, vascularity, and positional 
changes of the lesions. Imaging studies frequently used are USG, 
CT scans and MRI. 
These help to arrive at a differential Diagnosis. 
 
3. Tissue Diagnosis: This gives the definitive diagnosis and 
therapeutic decisions are made. 
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TISSUE DIAGNOSIS 
A tissue diagnosis is the final diagnosis and confirms the nature of the 
lesion. 
The tissue samples can be obtained by: 
PREOPERATIVE DIAGNOSIS:  Fine needle aspiration cytology 
INTRA and POST OPERATIVE DIAGNOSIS: Frozen section 
        Imprint Cytology 
        Incisional Biopsy 
        Excisional Biopsy 
        
 
FINE NEEDLE ASPIRATION CYTOLOGY: 
Fine needle aspiration cytology has an important application in clinical 
practice. It was defined by Banforth (1996) as one of the most useful 
component of non-exfoliative or clinical tissue cytology. 
For over a century diagnostic pathology had centered on surgical biopsy 
and histopathology. It is due to the pioneering work by Papanicolou, in 
the diagnosis of uterine carcinoma by exfoliative cytology from the 
accessible anatomical sites that the focus has now shifted to less invasive 
procedures which could serve both as a screening and diagnostic 
technique. 
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The History of needle biopsy has been traced to reports published in 1847 
by Kun.Greid and Grey in 1904, which demonstrated trypanasomal 
organisms in aspirates from lymph nodes. It was Guthrie in (1921) who 
reported the use of needle aspiration in the diagnosis of Malignant 
Lymphomas.  It was Martin and Ellis in 1927 at Memorial Hospital,USA, 
who reported 65 aspirations from a number of organs.  Confident 
diagnoses were made by including cell block preparations in their study. 
In 1930, Steward described aspiration in 2500 tumours from the same 
institute.  In Europe ,Zajicek and Franzen at Karolinska Hospital , 
Sweden were the first to describe precise diagnostic criteria in a variety of 
conditions in 1950. 
(10)
 
In 1972 , ocular lesion cytology was described by Naib
.(12)
 
In 1975 , FNAC in orbital tumours was described by Schyberg.
(8)
 
FNAC for intraocular tumours was proposed in 1979 by Jacobiec et al.
(9)
 
The gold standard method for diagnosis of tumours is Biopsy. FNAC is a 
safe, reliable, relatively non-invasive method that can be used in place of 
open biopsy. 
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FNAC is considered as an important preliminary diagnosis and can be 
used to diagnose easily palpable tumours of the breast, Lymph nodes, 
salivary glands,Orbit and eyelids.  
FNAChas also been done for deeper lesions inthe abdomen, 
retroperitoneal space,and prostate.  
The Accuracy can be increased by combining the procedure with USG/ 
CT guidance. 
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FINE NEEDLE ASPIRATION CYTOLOGY TECHNIQUE 
The procedure for FNAC is generally the same for any site in the body. 
An Ophthalmologist or Pathologist can safely do the procedure in the 
outpatient department under strict aseptic precautions. It can be done 
directly under vision or CT guidance. Local anaesthesia is generally not 
indicated. Using “sampling technique”, a 23 gauge needle is introduced 
into the lesion, moved in various directions and then withdrawn 
gently,wherein, the cellular aspirate moves into the needle by capillary 
action. 
The aspirate is then spreadover a slide, fixed in isopropylalcohol and 
stained with hematoxylin and eosin, examined and reported. 
Advantages and Limitations: 
The advantages of FNAC in eyelid and Orbital lesions are: 
 It is quicker to perform, easily repeatable, and can be done as an 
outpatient procedure with quick reporting of results without need 
for anaesthesia or orbitotomies. Results are obtained within a few 
hours. 
 Causes only minimal trauma at the site of interest. 
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 Can be used in patients who are severely ill with risk factors for 
anaesthesia and surgery. 
 When the suspected tumour doesn’t require surgical intervention 
for treatment, such as, Lymphoma, Metastatic tumours, 
Rhabdomyosarcoma, infections, sarcoidosis.  
 More cost effective as it avoids unnecessary admissions, saves time 
and makes use of minimal instrumentation. 
FNAC in Orbital and eyelid lesions can be used to differentiate between 
malignant and benign lesions with ease.  
 
Limitations of FNAC in Orbit and Eyelid lesions are: 
 Deep seated orbital lesions are to be avoided due to the risk of 
retrobulbar haemorrhage.  Risk can be reduced by using USG 
guidance for deep seated lesions. 
 Lacrimal gland tumoursare to be avoided for the risk of breaching 
the capsule and local metastasisalong needle biopsy track. 
 Fibrous nature of tumour leads to difficulty in diagnosis. 
 Sample adequacy is important as an accurate diagnosis cannot be 
made if haemorrhagic aspirate or insufficient material is aspirated. 
 Rare potential complications are penetration of the sclera, 
Diplopia and Ptosis. 
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TISSUE BIOPSY 
A Biopsy can be Incisional or Excisional. An excisional biopsy serves as 
both diagnostic and as treatment.  
Incisional:  using a blade or a biopsy punch, in which onlya part of the 
lesion is removed to allow histological diagnosis.Usually done in 
suspected malignant lesions. 
Excisional: in which the entire lesion is removed and a histological 
diagnosis made;  
Usually indicated for suspected benign lesions,cystic lesions, well 
circumscribed and encapsulated lesions such as Dermoid, cavernous 
hemangioma, pleomorphic adenomaof lacrimal gland, neurilemoma and 
fibroushistiocytoma. Biopsy has the added advantage of being therapeutic 
in such cases. 
In Orbital lesions obtaining sample for tissue diagnosis may warrant an 
orbitotomy.  
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In the eyelid lesionsexcision biopsy may be of the following types: 
1 Shave excision using a blade to remove shallow epithelial 
tumours, such as papillomas and seborrhoeic keratosis 
2  Full-thickness skin excision for tumours that are not confined to 
the epidermis. 
Biopsy obtained samples are fixed in 10% formaldehyde to preserve 
morphology ,  dehydrated in graded alcohol , cleared in xylene and 
embedded in paraffin wax. 5 – 6 micron thick sections made, stained 
using Hematoxylin and Eosin, examined by the pathologist and reported. 
This process takes a minimum of 5 days. 
 
Other techniques: 
Core Biopsy: It is a more invasive procedure compared to FNAC and 
makes use of a 2-4mm diameter trephine. Passed into the lesion after 
sufficiently anesthetizing the area with a gradual rotatory motion and the 
specimen is obtained.It has the advantage of being a rapid procedure with 
quicker reporting and can be done for deeper lesions but it requires more 
expertise and is a much more invasive procedure as compared to  
FNAC.  
(16)
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Frozen section: also known as cryosection and it involvesthe histological 
examination of the margins of the excised specimen during surgery to 
ensure tumour cell free margins.  If tumour cells are present in a 
particular area, further excision is performed until the specimen is tumour 
free. Although the results are obtained immediately, it requires more 
expertise, the use of a microkeratome known as cryostat, and the quality 
of slides to be examined is lower than the traditional histology 
techniques. 
(17,18)
 
Moh’s micrographictechnique:Fig (4) 
This technique was founded by Frederick mohs in the 1930’s.  
In this technique, layered excision of the tumour is carried out, colour 
coded using dyes,fixed, processed and a map of the edges of the tumour 
is created.  
If tumour cells are still present, further tissue excision is done till 
clearance is achieved.  
This procedure requires considerable expertise, is time-consuming, but 
minimizes the removal of normal tissue and maximizes the removal of 
the tumour cells.  
It gives minimal recurrence rate and is very useful in eyelid tumours 
where reconstruction plays an important role. 
(19,20,21,22)
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Fig 4.Procedure of Moh’s micrographic technique: 
  
Step 1 showing tumour site, step 2 showing schematic removal of visible 
portion of tumour. 
   
Step 3: showing division of excised tissue into quadrants and staining 
with colour dyes and a map of tissue made. 
Step 4: checking the excised quadrant for any residual tumour cells. 
 
Step 5: removal of residual tumour and steps 3 & 4 repeated till tumour free 
margins are obtained.  
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REVIEW OF LITERATURE 
FNAC is a safe, reliable, relatively non-invasive method that can be used 
in place of open biopsy.
(13)
 
In 1972, ocular lesion cytology was described by Naib.
(12)
 
In 1975, FNAC in orbital tumours was described by Schyberg. 
(8)
 
FNAC for intraocular tumours under imaging guidance was proposed in 
1979 by Jacobiec et al.
(9)
 
Various studied were carried out at research institutes which supported 
the view that FNAC could be considered as a first line investigation in 
eyelid and orbital lesions. 
JanW M Tijl, Leo Koorneef et al studied 46 cases of orbital lesions over a 
period of 6 years. They found an accuracy of up to 81% with Histo 
pathological control
(11)
. 
Asadi Amoli et al studied 62 orbital cases over one and a half years and 
they found out the procedure to be safe  , with a sample adequacy of  
66.66% in benign and 82.6% in malignant lesions and with an accuracy 
of 94.73% in malignant and 57.69% in benign lesions
(13)
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M.H.Roozitalab et al studied 26 lesions of various eyelid (12) and orbital 
tumours (14), and found out FNAC to be safe, with consistent diagnosis 
in >85% of the cases with easy differentiation of the lesions into benign 
and malignant lesions.
(12)
 
Vemuganti GK et al reported an accuracy of >90% in eyelid and orbital 
lesions.
(14)
 
Ketki Bagchi et al studied 30 cases of various eyelid and orbital lesions 
over a period of 3 years and found FNAC to be safe, with a diagnostic 
accuracy of 90%. For the malignant mass lesions they obtained a 
sensitivity rate of 95. 65% and specificity rate of 75%.
(15)
 
All the various studies show FNAC to be a safe procedure which can be 
done easily as an outpatient procedure with easy differentiation between 
benign and malignant lesions and with a diagnostic accuracy between  
81 – 95 %. 
FNAC in eyelid and orbital lesions are being studied to see the diagnostic 
accuracy in our population and in our setup.  
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AIMS AND OBJECTIVE 
OBJECTIVE/AIM 
To evaluate the diagnostic accuracy of FNAC in orbital and eyelid lesions 
in comparison to biopsy. 
PRIMARY OBJECTIVES 
To evaluate the diagnostic accuracy ofFNAC in Orbital and eyelid lesions 
in comparison to biopsy. 
SECONDARY OBJECTIVES 
1. To evaluate the safety profile of FNAC as compared to biopsy. 
2. To note the difference in time delay between specimen collection 
and reporting between FNAC and Biopsy. 
3. The role of FNAC as a primary investigation in Secondary orbital 
tumours.  
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MATERIALS AND 
METHODS 
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METHODOLOGY 
SUBJECT SELECTION:   
40 cases were included in the study which included 24 cases of eyelid 
lesions and 16 cases of anterior orbital lesions, which presented to our 
OPD over a period of 2 years. 
INCLUSION CRITERIA:  
1.  Solid Lesions >5mm, 
2.  Eyelid lesions and 
3.  Anterior orbital lesions  
EXCLUSION CRITERIA:  
1 Lacrimal gland lesions – for fear of breach of capsule and tumour 
seeding along the needle track 
2. Deep seated lesions – for fear of absence of visualization and risk 
of hemorrhage. 
3.    Pregnant women 
 
45 
REGISTRATION 
NAME:                                                AGE:              SEX:  M/F 
OCCUPATION:                                 ADDRESS: 
EYE INVOLVED:  RE/ LE 
 
HISTORY: 
A detailed history regarding of the presenting symptoms such as onset of 
lesion, duration,progression, any previous surgery and treatment of eye in 
the past, history of any loss of weight were asked for. Systemic factors 
like diabetes, hypertension, Ischemic heart disease, renal diseases were 
also asked for. 
A thorough evaluation of patients was performed which included general 
and ocular examination.  
General examination: 
General vital data like pulse, blood pressure, peripheral pulses were noted  
Ocular examination: 
 Eyelid: position of the eyelids, fullness and contour.  Site, size, 
colour of lesion. Associated tenderness if any. Consistency of 
lesion. 
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 Orbital lesion:site,size,tenderness, consistency of lesion, pulsations 
if any, variation with Valsalva manoeuvre, any displacement of the 
globe. 
 Visual acuity was recorded by Snellen’s chart in all cases. 
 Anterior segment examination by slit lamp examination, fundus 
examination by 90D and indirect ophthalmoscope was done. 
 Tension recorded by Applanation tonometry. 
 Colour vision and field examination. 
Other Investigations: 
 BP, 
  RBS, 
 Complete Hemogram, 
 Bleeding time,  
 Clotting time. 
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TECHNIQUE OF FNAC 
 
All patients with solid anterior orbital and lid lesions, after obtaining the 
patients consent, were subjected to FNAC in the Outpatient department 
under aseptic precautions fig(5). 
 
All the FNAC were performed without local anesthesia by using a fine 
23G, 3cm long needle attached to a 10ml disposable syringe .The lesions 
were palpated  and Using the “sampling technique”, once the needle was 
in the lesion, maximum retraction of the plunger was maintained and after 
a gentle to and fro movement in various directions,the plunger was 
released, and after the aspiration, 2 slides were prepared for each lesion  
and were immediately fixed with isopropyl alcohol and sent for 
examination. 
 
After reporting the FNA results, Biopsy of the aspirated masses were 
performed in the patients as an elective procedure in the operating theatre. 
A comparison of the diagnoses between the FNAC & Biopsy results, 
adequacy of samples and time taken from obtaining the sample, to 
reporting of results were also made. 
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Fig 5. TECHNIQUE OF FNAC 
 
Fig showing an eyelid lesion 
 
Fig showing the palpation of lesion under aseptic precautions 
 
Fig  showing the 23gauge needle with attached 10cc syringe  
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Fig  showing  aspiration of lesion using sampling technique 
 
Fig  showing preparation of slide 
 
Fig showing the coupling jar which contains 10% isopropyl  
alcohol in which the slides are fixed 
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RESULTS 
 
40 patients were included in this prospective study which included: 
 24 cases of eyelid lesions. 
 16 cases of orbital lesions. 
 
1. AGE DISTRIBUTION 
The following table shows the age distribution in the 24 patients of eye 
lid lesions. 
Table (1) – age distribution in eyelid lesions 
Age group No. of patients % 
1-10 1 4.16 
11-20 2 8.33 
21-30 1 4.16 
31-40 2 8.33 
41-50 3 12.5 
51-60 8 33.33 
61-70 4 16.66 
71-80 3 12.5 
Total 24 100 
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Graph 1 – showing the age distribution in patients with eyelid lesions 
 
 
A total number of 24 cases of eyelid lesions were studied.The maximum 
number of cases, 33.33% (8 patients), were seen in the age group of 
between 51-60 years. 
 The youngest patient included in the study was of 3 years while the 
oldest patient was of 75 years old. 
.   
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Age in years 
Table (2) – age distribution of patients in orbital lesions 
Age group No. of patients % 
1-10 3 18.75 
11-20 1 6.25 
21-30 0 0 
31-40 4 25 
41-50 2 12.5 
51-60 1 6.25 
61-70 5 31.25 
Total 16 100 
 
Graph (2) age distribution in orbital lesions 
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A total of 16 patients were included in the study out which the maximum 
number of patients 31.25% (5 patients) belonged to the age group 
between 61-70. 
The youngest patient included in the study was a one and a half year old 
patient and the oldest patient was of 65 years.  
 
2. SEX DISTRIBUTION 
The sex distribution in patients with eyelid lesions and orbital lesions are 
tabulated as follows: 
TABLE – 3 Sex distribution in patients of eyelid lesions 
 Frequency % 
Male 14 58.33 
Female 10 41.66 
Total 24 100 
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Males 
58.33% 
Females 
41.66% 
Sex distribution of eyelid lesions 
Graph 3 - sex distribution in patients with eyelid lesions 
 
 
 
 
 
Out of the 24 eyelid lesions studied, the majority were males and they 
constituted 58.33% of the group, while females constituted 41.66% of the 
group. 
TABLE – 4 Sex distribution in patients of orbital lesions 
 Frequency % 
Male 9 56.25 
 Female 7 43.75 
 Total 16 100 
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Males 
56.25% 
Females  
43.75% 
Sex distribution in orbital lesions 
 
Graph 4 – sex distribution in patients with orbital lesions 
 
 
 
 
 
 
 
Out of the 16 orbital lesions studied, the majority of the patients 56.25% 
were males, while females made up the remaining 43.75% of the group 
under study.  
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3. LATERALITY 
Table 5 – showing laterality of eyelid and orbital lesions. 
LESION RE LE Total 
Eyelids 15 9 24 
Orbital 6 10 16 
 
Graph 5 – showing laterality of eyelid and orbital lesions. 
 
Out of the 24 patients of eyelid lesions studied, 62.5% (15 patients) 
belonged to the right eye while 37.5% (9 patients) had lesions in the left 
eye. 
Similarly, in the 16 patients of the orbital lesions group, only 37.5% (6 
patients) had lesions in the righteye, while 62.5% (10 patients) had 
lesions in the left eye. 
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4. LID INVOLVEMENT 
 
Table 6 – showing lid involvement in eyelid lesions 
Upper lid Lower lid Total 
19 cases – 79.16% 5 cases – 20.83% 24 cases 
 
Graph 6 – showing lid involvement in eyelid lesions. 
 
The majority of the eyelid lesions 79.16% of cases belonged to the upper 
eyelid, the lower eyelid constituted the remaining 20.83 %. 
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5. FNAC SAMPLE ADEQUACY 
Table 7.Showing sample adequacy in eyelid and orbital lesions 
LESION ADEQUATE % INADEQUATE % TOTAL 
Eyelid 23 95.8% 1 4.16% 24 
Orbit 15 93.75% 1 6.25% 16 
 
Out of the 24 eyelid lesions, 23 of the aspirates were adequate for an 
FNAC diagnosis. That is, a sample adequacy of 95.8%. Only 1 aspirate or 
4.16% was inadequate. 
Similarly, in the 16 orbital cases, sample adequacy of 93.75% (15 cases) 
was noted, whereas 6.25% of samples (1 aspirate) were inadequate. 
Graph 7: showing sample adequacy in eyelid and orbital lesions 
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6. CORRELATION OF MALIGNANT AND BENIGN 
LESIONS ON FNAC & BIOPSY 
The final diagnosis was confirmed by histopathological examination of 
tissue biopsy. The nature of the lesions are as follows: 
 Eyelid lesions: No of benign lesions – 10, Malignant lesions – 14. 
 Orbital lesions: No. of benign lesions - 8, Malignant lesions -8. 
In FNAC, Positivity for malignancy was shown by cellular atypia, 
nuclear pleomorphism, irregular nuclear membrane or prominent 
nucleoli. 
Out of the 38 adequate samples, (23 eyelid and 15 orbital samples), the 
no of aspirates, which showed benign characteristics and the number of 
aspirates which showed positivity for malignancy are compared with 
HPE as follows: 
Table 8: FNAC comparision to the nature of lesion with HPE for eyelid lesions 
HPE diagnosis 
FNAC diagnosis Total 
Malignant Benign Inadequate  
Malignant 14 (100%) - - 14 
Benign - 9 (90%) 1 10 
 
 
61 
Table 9: FNAC comparision to the nature of lesion with HPE for orbital lesions 
HPE 
diagnosis 
FNAC diagnosis Total 
Malignant Benign Inadequate  
Malignant 8 - - 8 
Benign - 7 1 8 
 
Summarizing the % of benign and malignant lesions on FNAC for eyelid 
and orbital lesions  
Table 10: Percentage of Benign and malignant samples noted on FNAC  
Lesion Benign 
lesion 
% Benign Positive for 
Malignancy 
% Malignant 
Eyelids 9 39.13% 14 60.86% 
Orbit 7 46.66% 8 53.33% 
 
Out of the adequate eyelid samples, 60.86% (14 aspirates) were positive 
for malignancy while the remaining 39.13% (9 aspirates) were reported 
as benign. 
Similarly, 53.33 % of adequate orbital aspirates showed positivity for 
malignancy while  46.66% (7 cases) showed a benign nature of the 
aspirate. 
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Graph 8: Showing FNAC % for benign & malignant lesions   
 
 
 
 
 
7. FNAC v/s Biopsy Correlation  
After obtaining the FNAC reports, the biopsies of the respective lesions 
were carried out as an elective procedure, underanaesthesia and the 
results collected, tabulated and the FNAC results were compared with the 
same. 
Among the eyelid lesions: No of benign lesions – 10,  
Malignant lesions – 14. 
Among the Orbital lesions: No. of benign lesions - 8,  
Malignant lesions -8. 
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The tabulated results are as follows: 
Table 9: Biopsy v/s FNAC for patients with eyelid lesions   
HPE DIAGNOSIS 
Benign/ 
Malignant 
FNAC Diagnosis Correlation 
Total 
Inadequate   
Exact 
correlation 
Indefinite 
Dermoid Benign 0 1 0 1 
Epidermoid Benign 0 2 0 2 
Inflammatory lesion Benign 0 2 0 2 
Sebaceous cyst Benign 0 1 0 1 
Infected cyst Benign 0 1 0 1 
Neurofibroma Benign 1 0 2 3 
Sebaceous cell ca Malignant 0 7 0 7 
Squamous cell ca Malignant 0 4 0 4 
Basal cell 
Carcinoma 
Malignant 0 2 0 2 
Malignant 
Melanoma 
Malignant 0 1 0 1 
Total  1 21 2 24 
 
Inadequate aspirate: Out of the 24 aspirates, 1 aspirate (4.16%) was 
inadequate and had shown only proteinaceous fluid.  HPE confirmed this 
lesion as neurofibroma. 
Indefinite diagnosis: Out of the 23 adequate aspirates,indefinite 
diagnosis were seen in 2 aspirates (8.69%), both of them had shown the 
lesion to be a benign spindle cell tumour.  HPE confirmed both these 
lesions as neurofibroma. 
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Exact Correlation: Out of the 23 adequate aspirates,91.30%(21 
aspirates) showed an exact correlation with the HPE diagnosis. 
 
Graph 9: FNAC vs Biopsy for patients with benign & 
malignant eyelid lesions 
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Table 10.  Biopsy vs FNAC Anterior Orbital lesions  
HPE 
DIAGNOSIS 
Benign/ 
Malignant 
FNAC Diagnosis Correlation 
Total 
Inadequate   
Exact 
correlation 
Indefinite 
Epidermoid Benign   1  1 
Hemangioma Benign  1  1 
Pseudotumour Benign  2  2 
Neurofibroma Benign   1 1 
Teratoma Benign  1  1 
Schwanomma Benign   1 1 
Solitary fibrous 
tumor 
Benign   1 1 
Non – Hodgkins 
Lymphoma 
Malignant  5  5 
Ewings sarcoma Malignant  1  1 
Signet ring Ca Malignant  1  1 
Chloroma Malignant 1   1 
Total  1 14 1 16 
 
Inadequate aspirate: Out of the 16 aspirates, 1 aspirate (6.25%) was 
inadequate and had shown no cells.  HPE confirmed this lesion as 
Chloroma. 
Indefinite diagnosis: Out of the 15 adequate aspirates,indefinite 
diagnosis were seen in 3 aspirates (20.00%), two of them had shown the 
lesion to be a benign spindle cell tumour.  HPE confirmed one of this 
lesion as neurofibroma. The other benign spindle tumour was confirmed 
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as a Schwanomma. The third indefinite sample on FNAC showed a 
benign epithelial tumour. HPE confirmed the lesion to be a Solitary 
Fibrous tumour. 
Exact Correlation: Out of the 15 adequate aspirates, 80.00%  
(12 aspirates) showed an exact correlation with the HPE diagnosis 
 
Graph 10: Biopsy vs FNAC Anterior orbital lesions 
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8. TIME OF OBTAINING RESULTS 
After obtaining the FNAC samples for cytology, the time from obtaining 
the sample to the time of obtaining the results were documented. 
All cytology reports (40 cases) were received within 6 hours of sending 
the aspirates. 
All HPE reports (40 cases) were received on the 5
th
 day of sending 
Biopsy samples.  
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FNAC AND BIOPSY OF EYELID LESIONS 
      
Fig of patient  5;146/12  showing FNAC of Sebaceous cell carcinoma 
showing cellular atypia and vacuolated cytoplasm and its HPE showing 
malignant sebaceous cells with vacuolated cytoplasm  
 
 
  
Fig of patient 1; 279/10 FNAC showing malignant squamous cells & 
HPE of Squamous cell carcinoma with keratin pearls.Case of Squamous 
cell carcinoma. 
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Fig of patient 18;224/13 FNAC showing benign nature with 
inflammatory cells and HPE confirming benign lesion with sheet of 
histiocytes with lymphoid follicle. No cellular atypia. Case of chronic 
inflammatory lesion. 
 
  
Fig of patient 9;375/12 FNAC showing benign nature of lesion with 
spindle shaped cells & HPE showing benign lesion with sheets of spindle 
shaped cells. Case of Neurofibroma. 
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FNAC & BIOPSY OF ORBITAL LESIONS 
         
Fig  of patient 27;242/11 FNAC showing cellular atypia with small round 
cells with attempted rossette forrmation.  HPE showing cellular atypia , 
small cells with infiltration. Case of Ewings sarcoma.  
 
 
     
Fig  of  patient 25;225/11 FNAC showing sheets of lymphoid cells with 
atypia. HPE showing small round to oval sheets of lymphoid cells with 
atypia. Case of Non – Hodgkins Lymphoma 
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Fig of patient 36;380/12 FNAC showing benign lesion with mature 
adipoctyes, few squamous epithelial cells and anucleated squamous. HPE 
confirms benign case of Teratoma.  
 
        
Fig of patient 34;353/12 FNAC showing benign lesion with scanty cells 
with plump spindle shaped cells with elongated nuclei. HPE confirms 
benign nature of lesion with spindle shaped cells with verroucay bodies. 
Case of Schwanomma.   
 
 
72 
 
 
       
Fig. of patient 38;388/12 FNAC showing a benign epithelial neoplasm. 
HPE shows benign epithelial neoplasm with vascular spaces arranged in a 
patternless pattern. Case of solitary fibrous tumour. 
 
 
       
Fig of patient 37;109/12 FNAC Showing cellular atypia with Signet ring 
cells & HPE showing atypia with signet rings. Case of metastasis to the 
orbit by gastric adenocarcinoma. 
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STATISTICS 
Data was analyzed using SPSS software : 
 
Case Processing Summary 
 Cases 
 Valid Missing Total 
 N Percent N Percent N Percent 
fnac * biopsy 40 100.0% 0 .0% 40 100.0% 
 
 
fnac * biopsy Crosstabulation count 
  biopsy  
  .00 1.00 Total 
fnac .00 17 1 18 
1.00 0 22 22 
 Total 17 23 40 
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Chi-Square Tests 
 
Value df 
Asymp. 
Sig.  
(2-sided) 
Exact Sig.  
(2-sided) 
Exact Sig.  
(1-sided) 
Pearson Chi-Square 36.135
a
 1 .000   
Continuity Correction
b
 32.374 1 .000   
Likelihood Ratio 46.824 1 .000   
Fisher's Exact Test    .000 .000 
Linear-by-Linear 
Association 
35.232 1 .000 
  
N of Valid Cases 40     
a. 0 cells (.0%) have expected count less than 5. The minimum expected count is 
7.65. 
b. Computed only for a 2x2 table 
 
 
Symmetric Measures 
  
Value 
Asymp. Std. 
Error
a
 
Approx. 
T
b
 
Approx. 
Sig. 
Interval by 
Interval 
Pearson's R .950 .048 18.849 .000
c
 
Ordinal by 
Ordinal 
Spearman 
Correlation 
.950 .048 18.849 .000
c
 
 N of Valid Cases 40    
a. Not assuming the null hypothesis. 
b. Using the asymptotic standard error assuming the null hypothesis. 
c. Based on normal approximation. 
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Pearsonsα2  value: 0.950 was obtained. 
P value 0.001 
 
We found the sensitivity of FNAC for malignant lesions to be 88% 
and its specificity to be 100%.  
The positive predictive value of FNAC for malignant lesions is 100% 
and negative predictive value is 89%. 
Therefore, in our study we found FNAC to be a definite indicator of 
malignancy as confirmed by biopsy.  
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DISCUSSION 
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DISCUSSION 
1. Age: 
In our study of 40 cases, 24 cases of eyelid lesions and 16 cases of orbital 
lesions were included. 
Among the 26 eyelid lesions,the maximum number of cases, 33.33%  
(8 patients), belonged to the age group between 51-60 years. 
The youngest patient included in the study was a 3 year old male while 
the oldest patient was of 75 years old. 
Among the total of 16 patients of orbital lesions, themajority of patients 
31.25% (5 patients) belonged to the age group between 61-70. 
The youngest patient included in the study was a one and a half year old 
patient and the oldest patient was of 65 years.  
In our study we observed wide variation in the age incidences of eyelid 
and orbital lesions based on the etiology, but a majority of the eyelid 
cases were seen in the age group between 51 -60 years and the orbital 
cases in the age group of 61 -70.  
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2. SEX: 
Out of the 24 eyelid lesions studied, the majority were males and they 
constituted 58.33% of the group, while females constituted 41.66% of the 
group. 
Out of the 16 orbital lesions studied, the majority of the patients 56.25% 
were males, while females made up the remaining 43.75% of the group 
under study.  
In our study we observed eyelid and orbital lesions to be more common 
in the males. 
 
3. LATERALITY: 
In our study,out of the 24 patients of eyelid lesions studied, 62.5% (15 
patients) belonged to the right eye while 37.5% (9 patients) had lesions in 
the left eye. 
Similarly, in the 16 patients of the orbital lesions group, only 37.5% (6 
patients) had lesions in the righteye, while 62.5% (10 patients) had 
lesions in the left eye. 
In our study we found eyelid lesions to be more common in the right eye 
while left eye involvement was commoner in patients with orbital lesions. 
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4.  LID INVOLVEMENT: 
The majority of the eyelid lesions, 79.16% belonged to the upper eyelid, 
the lower eyelid constituted the remaining 20.83 %  
In our study we found out upper eyelid involvement to be very common 
 
5.  FNAC SAMPLE ADEQUACY  
Out of the 24 eyelid lesions, 23 of the aspirates were adequate for an 
FNAC diagnosis. That is, a sample adequacy of 95.8%. Only 1 aspirate or 
4.16% was inadequate. 
Similarly, in the 16 orbital cases, sample adequacy of 93.75% (15 cases) 
was noted, whereas 6.25% of samples (1 aspirate) were inadequate. 
In our study FNAC samples were adequate for commenting on the 
cytopathological characteristics of the lesions.   
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6. BENIGN & MALIGNANT CHARACTERISTICS FNAC VS 
BIOPSY 
In our study we compared the FNAC samples with the tissue biopsies of 
the 24 eyelid and 16 orbital lesions. 
Out of the HPE proven 14 eyelid malignantlesions, FNAC showed 
positivity for malignancy in all 14 of the samples. 
Out of the HPE proven 10 benign eyelid lesions, FNAC showed absence 
of malignancy in the 9 adequate samples.   
Out of the HPE proven 8 orbitallesions, FNAC showed positivity for 
malignancy in all 8 of the samples. 
Out of the HPE proven benign 8 orbital lesions, FNAC showed absence 
of malignancy in 7 of the adequate samples. 
 
Summarizing, FNAC was able to detect malignancy in 100% of the cases. 
Therefore, in our study we found out that FNAC in adequate samples is 
an excellent tool to find out the nature of the lesion in both eyelid and 
anterior orbital lesions. 
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7. FNAC vs Biopsy tissue diagnosis correlation 
JanW M Tijl, Leo Koorneef et all studied 46 cases of orbital lesions and 
they found an accuracy of up to 81% with Histo pathological control
(11).
 
M.H.Roozitalab et al studied 26 lesions of various eyelid (12) and orbital 
tumours (14), and got a consistent diagnosis in >85% of the cases.
(12)
 
Vemuganti GK et al reported an accuracy of >90% in eyelid and orbital 
lesions.
(14)
 
Ketki Bagchi et al studied 30 cases of various eyelid and orbital lesions 
over a period of 3 years and found a diagnostic accuracy of 90%.
(15) 
In our study, out of the 23 adequate eyelid aspirates,91.30%(21 aspirates) 
showed an exact correlation with the HPE diagnosis. 
And out of the 15 adequate orbital aspirates, 80.00% (12 aspirates) 
showed an exact correlation with the HPE diagnosis. 
In our study FNAC in adequate samples was able to accurately 
diagnose the lesions in 91.30% of eyelid lesions and 80.00% of orbital 
lesions. 
Among the cases of indefinite diagnoses, 8.69% in eyelids and 20% in 
orbital lesions, FNAC was able to diagnose the benign nature of the 
lesion and the basic architecture of the lesion. 3 lesions were found to 
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have a benign spindle tumour like pattern and 1 lesion was found to have 
benign epithelial component with few fibrous tissue.2 benign spindle 
tumours were confirmed as neurofibroma on HPE. 1 benign spindle 
tumour was confirmed as Schwanomma. The benign epithelial neoplasm 
was confirmed as a solitary fibrous tumour. 
Even a rare tumour such as Ewings Sarcoma of the orbit was diagnosed 
on FNAC. 
In our study  
Pearsonsα2  value: 0.950 was obtained. 
P value 0.001 
This shows that FNAC in eyelid and orbital lesions is a reliable 
diagnostic tool. 
The sensitivity of FNAC for malignant lesions to be 88% and its 
specificity to be 100%. 
The positive predictive value of FNAC for malignant lesions is 100% 
and negative predictive value is 89%. 
Therefore, in our study we found FNAC to be a definite indicator of 
malignancy as compared to biopsy.  
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8.  RAPIDTIY OF PROCEDURE 
In our study all our cytopathology reports were obtained within 6 hours of 
obtaining the specimen while biopsy reports for eyelid and orbital lesions 
were obtained on the 5
th
 day of obtaining the specimen. 
Therefore, our study shows that FNAC is an excellent tool for rapid 
diagnosis of eyelid and orbital lesions.   
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CONCLUSION 
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CONCLUSION 
 FNAC of eyelids and orbit is a safe procedure, can be done without 
anaesthesia in the outpatient department.  
 FNAC can be done in patients who are not fit for surgery nor have 
high risk for anaesthesia.  
 FNAC delivers results within 5-6 hours.   
 FNAC differentiates lesion as benign or malignant easily. 
 FNAC can be considered as a first diagnostic investigation of 
choice in tumours such as,Lymphoma, Metastatic tumours, 
infections that don’t require surgical intervention for treatment. 
 
FNAC gives rapid results and correlates highly with Tissue biopsy 
proven HPE, FNAC can be considered as a primary investigation in 
the diagnosis of eyelid and anterior orbital lesions and can be done 
safely as an outpatient procedure. 
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PART III 
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PROFORMA 
 
Evaluation of case of Orbital and eyelid lesion. 
 
Name:     Age:    Sex: 
Occupation:    Address: 
Regn. Number 
 
Presenting complaints: 
 
History of present illness: 
 
Eyelid / Orbital lesion : Onset and Progression 
Defective vision: 
Pain scoring: 
History of trauma: 
 
Other history:  Thyroid disease , sinusitis, aggravation with 
respiratory infections, History of weight loss if any , History of associated 
neck swellings or lymph nodes. 
 
Treatment history 
Past History:  
Similar complaints in the past . 
H/O Thyroid disease , HIV, anticoagulants , Tuberculosis , Diabetes ,  
Hypertension or any known drug reactions. 
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Family history: 
 
Personal history: 
General systemic examination: 
Pulse:      Pallor  
BP:       Icterus 
Neck Swellings    Lymphadenopathy 
CVS:      Respiratory System: 
Abdominal Examination:   ENT Examination 
 
 
Ocular examination: 
 
Visual acuity 
Refraction 
Color Vision: 
Visual fields  
 
 
Orbital & eyelid lesion: 
 
Inspection: 
Compensatory head posture: 
Facial symmetry: 
Ocular symmetry: 
Mass description: 
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Eyelids 
Position (MRD1 and MRD2): 
Fullness 
Contour 
Movements/Lid Lag 
Lagophthalmos 
Mass lesion  
Palpebral fissure height 
 
Orbital lesion : 
 
Pulsations 
MEASUREMENTS: 
Hertel's (B.R……mm) 
Horizontal 
Vertical 
Valsalva maneuver: 
Periocular changes 
 
Conjunctiva 
Cornea 
Anterior chamber 
Pupil 
Lens 
Fundus 
Ocular motility 
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Palpation: 
Bony regularity: 
Temperature : 
Tenderness: 
Crepitus: 
Description of Mass: 
 
Thrill/ Reducibility: 
Retropulsion: 
 
Fundus Examination: 
 
Impression: (D/D): 
 
 
Procedure : 
 
FNAC: 
 
Procedure Performed: 
 
 
HPE Diagnosis: 
 
Postop followup: 
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SR. 
NO
IP No NAME AGE SEX LATERALITY SITE
FNAC SAMPLE 
ADEQUACY
FNAC 
positive/negative for 
malignancy
FNAC Result Biopsy Result CORRELATION
1 279/10 Krishnan 56 M LE UL nodular Adequate positive Squamous cell Ca Squamous cell Ca Yes
2 69/12 Lakshmi 60 F RE LL ulcerative lesion Adequate positive Basal Cell Ca Basal Cell Ca Yes
3 158/12 Muniyammal 55 F LE UL pigmented Adequate positive Melanoma Melanoma Yes
4 414809 Nandhini 13 F LE UL firm lesion Inadequate Inadequate protenceous fluid Plexiform Neurofibroma Inadequate
5 146/12 Laxmi 65 F LE UL nodular Adequate positive Sebaceous Cell Ca Sebaceous Cell Ca Yes
6 475843 Natchimuthu 75 M RE UL ulcerative Adequate positive Squamous cell Ca Squamous cell Ca Yes
7 278/12 Sasikala 18 F RE UL firm lesion Adequate negative Dermoid cyst Dermoid cyst Yes
8 354/12 Velusamy 60 M LE UL Nodular Adequate positive Sebaceous Cell Ca Sebaceous Cell Ca Yes
9 375/12 Ponniyammal 67 F RE UL firm lesion Adequate negative Benign spindle cell Neurofibroma Indefinite
10   6/13 Krishna 69 M RE UL ulcerative Adequate positive Sebaceous Cell Ca Sebaceous Cell Ca Yes
11 21/13 Sudhakar 3 M LE UL firm lesion Adequate negative Infected cyst Infected cyst yes
12 108/13 Kumar 39 M RE UL firm lesion Adequate negative Epidermoid cyst Epidermoid cyst Yes
13 164/10 Shalini 21 F RE UL firm lesion Adequate negative Benign spindle cell Neurofibroma Yes
14 179/13 Shanmugam 55 M RE UL firm lesion Adequate negative Epidermoid cyst Epidermoid cyst Yes
15 44/13 Kanagarasu 48 M LE UL ulcerative Adequate positive Sebaceous Cell Ca Sebaceous Cell Ca Yes
16 204/13 Kasturi 55 F RE LL fungating lesion Adequate positive Squamous cell Ca Squamous cell Ca Yes
17 212/13 Suguna 58 F RE UL ulcerative Adequate positive Basal Cell Ca Basal Cell Ca Yes
18 224/13 Mohamed 72 M RE UL firm lesion Adequate negative Inflammatory lesion Inflammatory lesion Yes
19 290/13 Venkatesh 48 M RE UL firm lesion Adequate negative Sebaceous Cyst Sebaceous cyst Yes
20 373/13 Selvam 48 M RE UL nodular Adequate positive Sebaceous Cell Ca Sebaceous Cell Ca Yes
21 448/13 Sagayam 54 M RE LL nodular Adequate positive Sebaceous Cell Ca Sebaceous Cell Ca Yes
22 181/13 Jayaraman 75 M LE LL ulcerative lesion Adequate positive Squamous cell Ca Squamous cell Ca Yes
23 286/13 Panja 39 M LE LL nodular Adequate positive Sebaceous Cell Ca Sebaceous Cell Ca Yes
24 262/12 susaiammal 60 F RE UL firm lesion Adequate negative Inflammatory lesion Inflammatory lesion Yes
25 227/11 Raja 46 M LE Ant Sup Orbital Mass Adequate positive Non-Hodgkins lymphoma Non-Hodgkins Lymphoma Yes
26 314/10 Kannamal 65 F LE Ant Inf Orbital Mass Adequate positive Non-Hodgkins lymphoma Non-Hodgkins Lymphoma Yes
27 242/11 Vijaykrishnan 1.5 M LE Inf Orbital Mass Adequate positive PNET/EWINGS Ewings Yes
28 278/11 Moorthy 65 M LE Ant Inf Orbital Mass Adequate positive Non-Hodgkins lymphoma Non-Hodgkins Lymphoma Yes
29 131/10 Sambandan 66 M LE Ant Sup Orbital Mass Adequate positive Non-Hodgkins lymphoma Non-Hodgkins Lymphoma Yes
30 180/12 Chellapan 65 M LE Ant Inf Orbital Mass Adequate positive Non Hodgkins Lymphoma Non-Hodgkins Lymphoma Yes
31 188/12 Kuppuraj 35 M RE Ant Sup Orbital Mass Adequate negative Benign epithelial Neoplasia Solitary Fibrous Tumour Indefinite
32 213/12 Palani 35 M LE Ant Sup Orbital Mass Adequate negative Epidermoid cyst Epidermoid cyst Yes
33 241/12 Dhanam 40 F RE Ant Sup Orbital Mass Adequate negative Benign Neoplasm Hemangioma Yes
34 353/12 Gowri 47 F RE Ant Sup Orbital Mass Adequate negative Benign spindle cell tumour Schwanomma Indefinite
35 359/12 Nagammal 53 F LE Ant Inf Orbital Mass Adequate positive Non-Hodgkins lymphoma Non-Hodgkins Lymphoma Yes
36 380/12 Ramya 9 F RE Ant Inf Orbital Mass Adequate negative Teratoma Teratoma Yes
37 109/12 Narasammal 33 F LE Ant Inf Orbital Mass Adequate positive Signet Ring Ca /Mets Signet Ring Ca Yes
38 116/12 Sheikh Abdul 62 M RE Ant Sup Orbital Mass Adequate negative Pseudotumour Pseudotumour Yes
39 242/13 Ganesan 5 M RE Ant Sup Orbital Mass Inadequate Inadequate Inadequate Chloroma Inadequate
40 412/13 Mohana 14 F LE Ant Sup Orbital Mass Adequate negative Benign spindle cell tumour Neurofibroma Yes
